Jennifer Brooks Crozier


Jennifer Crozier
Jennifer Brooks Crozier is counsel in Weil’s Complex Commercial Litigation practice. She has significant experience litigating a broad variety of complex, high-stakes disputes in state and federal courts around the U.S., including the defense of breach of contract, fraud, business tort, unfair business practice, products liability, and drug and medical device claims, as well as consumer class actions.

Jennifer has participated in every phase of complex litigation, including at trial and in arbitration, on behalf of clients in the medical device, pharmaceutical, financial services, investments, semiconductor manufacturing, e-commerce, satellite services, and energy sectors, as well as on behalf of debtors and stakeholders in contested litigation matters in corporate restructurings. She has taken a lead role in conducting direct- and cross-examinations at trial and in arbitration, conducting depositions, preparing expert witnesses, drafting and arguing summary judgment, Daubert, and other motions, and managing trial teams. Some of her recent notable experience includes serving on Weil teams that:

  • Represent a leading American biotechnology company in connection with a multidistrict patent litigation brought pursuant to the Biologics Price Competition and Innovation Act—specifically, managing the company’s opposition to the several defendants’ motions to dismiss for lack of personal jurisdiction or to transfer venue.
  • Successfully represented ExxonMobil in winning a complete defense jury verdict following four days of trial in the Eastern District of New York, in a multi-million dollar breach of contract suit brought by BP seeking attorneys’ fees related to BP’s defense of nearly two dozen environmental contamination lawsuits. Jennifer served as second-chair trial counsel on the Weil team.
  • Successfully represented a major e-commerce company in a contract dispute relating to a multi-year operating agreement with a former business partner. Following a five-day arbitration and post-trial briefing, secured a complete victory, including significant damages and a permanent injunction for the client.
  • Successfully defended a healthcare services provider against an application for entry of a status quo order and injunction filed in the Delaware Court of Chancery by its partner in a joint venture—after an expedited hearing on the healthcare services provider’s motion to dismiss, the plaintiff voluntarily dismissed its complaint and, through subsequent negotiation, the healthcare services provider secured its key commercial and strategic objectives before the Chancery Court even rendered a decision on the motion to dismiss.
  • Successfully defended a multinational pharmaceutical and medical-device manufacturer against an application for an injunction filed in the United States Bankruptcy Court for the District of Delaware by a tort claimants’ committee seeking to prevent the manufacturer from undertaking a major corporate transaction.
  • Won dismissal of a fraudulent inducement claim and other quasi-contract claims brought in the New York Supreme Court’s Commercial Division by an American multinational technology corporation against an American multinational semiconductor manufacturing and design company.
  • Defend a worldwide provider of legal services in an action brought in New York state court by a plaintiff seeking to recover damages for the provider’s alleged breach of an anti-assignment provision in connection with a merger-and-acquisition transaction. Weil prevailed on an interlocutory appeal to the Appellate Division of the trial court’s order denying our clients’ motion for summary judgment, securing a significant reversal of the trial court’s decision concerning the meaning and application of a contractual limitation-of-liability provision, and reducing the scope of the provider’s potential damages exposure by tens of millions of dollars.
  • Represent an American multinational oil and gas corporation as claimant in an arbitration proceeding to recover damages for the respondent’s breach of an agreement relating to groundwater remediation.
  • Defended chapter 11 debtors in an adversary proceeding brought in federal bankruptcy court in White Plains, New York and prevailed against plaintiff attempting to collect more than $88 million from debtors and to avoid assuming $166 million in liabilities pursuant to a contract with debtors.
  • Defended a multinational pharmaceutical and medical-device manufacturer in a months-long jury trial of four plaintiffs’ products-liability, breach of warranty, and misrepresentation claims brought in state court in New Brunswick, New Jersey.
  • Represented the ad hoc group of first-lien creditors of a North American industrials company in connection with the company’s chapter 11 cases and prevailed on a motion to quash the deposition of a corporate representative of the ad hoc group.
  • Won dismissal of a securities fraud claim brought in federal district court in Houston, Texas by a stockholder against an executive of a multinational oil and gas exploration corporation relating to an oil well explosion.
  • Defended a large retailer’s acceptance at auction of a prospective purchaser’s bid to purchase substantially all of the retailer’s assets and operations as a going concern in connection with the retailer’s chapter 11 bankruptcy filing.
  • Represented a U.S. healthcare company and national hospital-based physician group as plaintiff in a complex breach of contract suit to recover hundreds of millions of dollars in physician-services fees, which was tried to a jury verdict.

Jennifer is Chair of the New York State Bar Association’s Trial Advocacy Committee, whose mission is, among other things, to develop constructive and innovative advocacy training programs that improve the courtroom skills of trial advocates and to foster robust and sustained discourse about the legal, ethical, social, and economic issues confronting trial advocates today. Jennifer also maintains an active pro bono practice, in which she partners with organizations such as the Georgia Innocence Project to free the wrongly prosecuted through, among other avenues, DNA testing. Jennifer is a member of Weil’s women’s affinity group, Women@Weil, and participates in a number of internal firm mentoring initiatives. 

In 2021 and 2022, Jennifer was recognized as a New York Metro Rising Star by Super Lawyers in the area of civil litigation (defense) and, in 2018, Jennifer was recognized as a New England Rising Star by Super Lawyers in the area of products liability.

Before joining Weil, Jennifer worked as an associate at two national law firms, and prior to attending law school, taught Upper School English and history at the Hockaday School in Dallas,Texas.

Awards and Recognition, Firm News & Announcements

Awards and Recognition

Firm News & Announcements